Key result
Diuretic-based hypertension treatment reduced cardiovascular morbidity and mortality, including stroke and coronary heart disease events, compared with placebo or control.
Why the study?
Does diuretic-based treatment reduce cardiovascular morbidity and mortality in patients with hypertension?
Does diuretic-based treatment reduce cardiovascular morbidity and mortality in patients with hypertension?
Diuretics remain a preferred initial therapy for hypertension due to their proven efficacy in reducing cardiovascular morbidity, mortality, and related complications.
Answers are grounded in this paper and cite their sources.
Supports diuretic preference in hypertension; leaves open optimal comparisons with contemporary agents.
Diuretic-based hypertension treatment trials have universally demonstrated a reduction in cardiovascular morbidity and mortality in treated compared with placebo or control subjects. Progression to more severe hypertension has been reduced together with reversal of left ventricular hypertrophy if present and prevention of congestive heart failure. The incidence of fatal and non-fatal strokes as well as coronary heart disease events have both been significantly reduced by diuretic-based treatment. Speculation that diuretic-induced adverse effects on lipid and glucose metabolism have negated the beneficial effects of blood pressure lowering has not been substantiated. Diuretics remain one of the preferred initial therapies in the management of hypertension.
No takes yet. Share an insight, caveat, or question.
Marvin Moser (2008) conducted a review in Hypertension. Diuretics vs. Placebo or control was evaluated on Cardiovascular morbidity and mortality. Diuretic-based hypertension treatment reduced cardiovascular morbidity and mortality, including stroke and coronary heart disease events, compared with placebo or control.
Synapse has enriched 10 related papers. Consider them for comparative context: